or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed ...

GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...

After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.

GSK Plc said it will pay as much as ... to pay more than $100 million to settle about 4,000 Zantac-related lawsuits. Pfizer agreed to settle more than 10,000 related cases, Bloomberg reported ...

Oct 9 (Reuters) - GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company ...

GSK earlier this month agreed to pay $2.3 billion to end lawsuits alleging that Zantac ... deal in principle to pay $70 million to settle a separate Zantac case with US laboratory Valisure.

UK pharmaceutical giant GSK says ... have both agreed to settle cases. Boehringer Ingelheim is the exception. It has not announced any major settlements. A drug under the name of Zantac 360 ...

To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405. Settlement monies are not expected ...

A trial ended with a hung jury on Thursday in a California man's lawsuit alleging Boehringer Ingelheim's discontinued ...

However, due to the size of the class and final amounts still not approved, we do not expect swift settlement payments." To apply for a cash advance lawsuit loan from your anticipated GSK Zantac ...